These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3938855)

  • 21. The effects of almitrine at rest and on exercise in COPD patients.
    Feist H
    Eur J Respir Dis Suppl; 1986; 146():651-5. PubMed ID: 3096765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of the carotid body on gas exchange during exercise.
    Grassi C; Cerveri I; Rampulla C; Tantucci C; Grassi V
    Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():191s-194s. PubMed ID: 3690031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Vectarian international multicenter study (VIMS) in hypoxemic chronic bronchitis patients treated by the double-blind placebo method for 1 year. Follow-up of the monitoring of 490 patients].
    Ansquer JC
    Rev Med Interne; 1985; 6 Spec No():31-7. PubMed ID: 3914682
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of almitrine bismesylate on the distribution of ventilation and mechanics of breathing in patients with COLD.
    Yernault JC; Van Muylem A; Noseda A; Ravez P; Paiva M
    Eur J Respir Dis Suppl; 1983; 126():265-70. PubMed ID: 6373341
    [No Abstract]   [Full Text] [Related]  

  • 25. Long term studies on almitrine bismesylate in COPD patients.
    Bourgouin-Karaouni D; Mercier J; Prefaut C
    Eur J Respir Dis Suppl; 1986; 146():695-701. PubMed ID: 3096767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Almitrine per os in the therapy of chronic obstructive bronchopneumopathies].
    Seignalet C; Préfaut C; Gonzales C; Michel FB
    Rev Fr Mal Respir; 1980; 8(6):627-33. PubMed ID: 7027375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of almitrine bismesylate and medroxyprogesterone acetate on oxygenation during wakefulness and sleep in patients with chronic obstructive lung disease.
    Daskalopoulou E; Patakas D; Tsara V; Zoglopitis F; Maniki E
    Thorax; 1990 Sep; 45(9):666-9. PubMed ID: 2145654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Nocturnal hypoxemia of chronic obstructive bronchopathies and almitrine dimesylate].
    Racineux JL; Hubert P; Meslier N; Monrigal JP
    Rev Med Interne; 1985; 6 Spec No():39-42. PubMed ID: 3834559
    [No Abstract]   [Full Text] [Related]  

  • 29. Cardiopulmonary effects of a single oral dose of almitrine at rest and on exercise in patients with hypoxic chronic airflow obstruction.
    Simonneau G; Meignan M; Denjean A; Raffestin B; Harf A; Prost JF
    Chest; 1986 Feb; 89(2):174-9. PubMed ID: 2867861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement in ventilation-perfusion matching by almitrine in COPD.
    Mélot C; Naeije R; Rothschild T; Mertens P; Mols P; Hallemans R
    Chest; 1983 Mar; 83(3):528-33. PubMed ID: 6130897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Almitrine bismesylate and hypoxemia in COPD patients (results of an Italian multicentric trial).
    Vulterini S; Dardes N; Moreo GC; Chianese R; Maiorano V; Carnimeo N
    Eur J Respir Dis Suppl; 1986; 146():677-83. PubMed ID: 3536561
    [No Abstract]   [Full Text] [Related]  

  • 32. The acute effect of a single oral dose of 200 mg almitrine on gas exchange in patients with chronic obstructive bronchitis and emphysema, bronchial asthma and lung fibrosis.
    Magnussen H; Radenbach D; Kiwull-Schöne H
    Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():211s-214s. PubMed ID: 3690032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lung function and blood gas analysis studies in patients with COPD and respiratory insufficiency receiving almitrine medication with special reference to its clinical aspects].
    Hillebrand M; Siemon G
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():391-3. PubMed ID: 2902610
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pulmonary hemodynamic monitoring in chronic respiratory insufficiency treated with almitrine bismesilate for 4 months in a double-blind study].
    Bourgouin-Karaouni D; Ramonatxo M; Michel FB; Macabies J; Prefaut C
    Rev Mal Respir; 1984; 1(4):245-50. PubMed ID: 6505362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Should arterial gas values be improved in patients with chronic bronchitic respiratory insufficiency? Value of almitrine dimesylate].
    Prefaut C
    Presse Med; 1984 Oct; 13(34):2090-3. PubMed ID: 6149537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Almitrine bismesylate in chronic obstructive lung disease and persistent hypoxemia. Controlled double-blind study with oral administration].
    Wuttke R; von Wichert P
    Respiration; 1985; 48(4):285-95. PubMed ID: 3936140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pathologic altitude polycythemia: therapeutic trial with almitrine dimesylate].
    Guénard H; Villena M; Vargas E
    Rev Med Interne; 1985; 6 Spec No():11-3. PubMed ID: 3938852
    [No Abstract]   [Full Text] [Related]  

  • 38. [Almitrine dimesylate: ventilatory or vascular action].
    Préfaut C; Bourgouin-Karaouni D
    Rev Med Interne; 1985; 6 Spec No():3-7. PubMed ID: 3914681
    [No Abstract]   [Full Text] [Related]  

  • 39. [Current knowledge and future perspectives on almitrine dimesylate (Vectarion). 8th International Pneumo-Allergology Seminar in Montpellier (21-24 May 1985)].
    Rev Med Interne; 1985; 6 Spec No():1-63. PubMed ID: 3834558
    [No Abstract]   [Full Text] [Related]  

  • 40. Dose-response and pharmacokinetic study with almitrine bismesylate after single oral administrations in COPD patients.
    Bury T; Jeannot JP; Ansquer JC; Radermecker M
    Eur Respir J; 1989 Jan; 2(1):49-55. PubMed ID: 2495983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.